Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements

Nucleic Acids Research

Volumn 36, Issue 15, 2008, Pages 4845-4862

  Taylor, Jennifer M ^a   Wicks, Kate ^a   Vandiedonck, Claire ^a   Knight, Julian C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; DEOXYRIBONUCLEASE I; HISTONE H3; HISTONE H4; LYMPHOTOXIN; LYMPHOTOXIN BETA; NUCLEAR FACTOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS INHIBITOR LIKE 1 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UPSTREAM STIMULATORY FACTOR;

ARTICLE; CELL LINE; CELL SPECIFICITY; CELL TYPE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; DNA SEQUENCE; EXON; GENE LOCUS; GENE MAPPING; GENETIC CONSERVATION; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REPORTER GENE; SOUTHERN BLOTTING;

BASE SEQUENCE; BLOTTING, SOUTHERN; CELL LINE; CHROMATIN; CONSERVED SEQUENCE; DEOXYRIBONUCLEASE I; DNA FOOTPRINTING; ENHANCER ELEMENTS (GENETICS); HISTONES; HUMANS; JURKAT CELLS; LYMPHOTOXIN-ALPHA; PHYLOGENY; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TUMOR NECROSIS FACTORS;

EID: 50849117130     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn444     Document Type: Article

References (73)

1. The ENCODE Project Consortium (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.
2. Elgin,S.C. (1988) The formation and function of DNase 1 hypersensitive sites in the process of gene activation. J. Biol. Chem., 263 19259-19262.
3. Weintraub,H. and Groudine,M. (1976) Chromosomal subunits in active genes have an altered conformation. Science, 193, 848-856.
4. Wu,C. (1980) The 5′ ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I. Nature, 286, 854-860.
5. Crawford,G.E., Holt,I.E., Mullikin,J.C., Tai,D., Blakesley,R., Bouffard,G., Young,A., Masiello,C., Green,E.D., Wolfsberg,T.G. et al. (2004) Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc. Natl Acad. Sci. USA, 101 992-997.
6. Sabo,P.J., Humbert,R., Hawrylycz,M., Wallace,J.C., Dorschner,M.O., McArthur,M. and Stamatoyannopoulos,J.A. (2004) Genome-wide identification of DNasel hypersensitive sites usinr active chromatin sequence libraries. Proc. Natl Acad. Sci. USA, 101, 4537-4542.
7. Dorschner,M.O., Hawrylycz,M., Humbert.R., Wallace,J.C., Shafer,A., Kawamoto,J., Mack,J., Hall,R., Goldy,J., Sabo,P.J. et al. (2004) High-throughput localization of functional elements by quantitative chromatin profiling. Nat. Methods, 1, 219-225.
8. Crawford,G.E., Davis,S., Scacheri,P.C., Renaud,G., Halawi,M.J., Erdos,M.R., Green,R., Meltzer,P.S., Wolfsberg,T.G. and Collins,F.S. (2006) DNase-chip: A high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat. Methods, 3 503-509.
9. Follows,G.A., Dhami,P., Gottgens,B., Bruce,A.W., Campbell,P-J., Dillon,S.C., Smith,A.M., Koch,C., Donaldson,I.J., Scott,M.A. et al. (2006) Identifying gene regulatory elements by genomic microarray mapping of DNase I hypersensitive sites. Genome Res., 16, 1310-1319.
10. Sabo,P.J., Kuehn,M.S., Thurman,R., Johnson,B.E., Johnson,E.M., Cao,H., Yu,M., Rosenzweig,E., Goldy,J., Haydock,A. et al. (2006) Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays. Nat. Meth., 3, 511-518.
11. Tracey,K.J. and Cerami,A. (1993) Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol., 9, 317-343.
12. Kwiatkowski,D., Hill,A.V.S., Sambou,I., Twumasi,P., Castracane,J., Manogue,K.R., Cerami,A., Brewster,D.R. and Greenwood,B.M. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet, 336, 1201-1204.
13. Neurath,M.F., Fuss,I., Pasparakis,M., Alexopoulou,L., Haralambous,S., Meyer zum Buschenfelde,K.H., Strober,W. and Kollias,G. (1997) Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol., 27, 1743-1750.
14. Brennan,F.M., Chantry,D., Jackson,A., Maini,R. and Feldmann,M. (1989) Inhibitory effect of TNF alpha antibodies, on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet, 2, 244-247.
15. Tsytsykova,A.V. and Goldfeld,A.E. (2002) Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol. Cell Biol., 22, 2620-2631.
16. Falvo,J.V., Uglialoro,A.M., Brinkman,B.M., Merika,M., Parekh,B.S., Tsai,E.Y., King,H.C., Morielli,A.D., Peralta,E.G., Maniatis,T. et al. (2000) Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol. Cell Biol., 20, 2239-2247.
17. Tsai,E.Y., Falvo,J.V., Tsytsykova,A.V., Barczak,A.K., Reimold,A.M., Glimcher,L.H., Fenton,M.J., Gordon,D.C., Dunn,I.F. and Goldfeld,A.E. (2000) A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recndted to the tumor necrosis factor alpha promoter, in vivo. Mol. Cell Biol., 20 6084-6094.
18. Barthel,R., Tsytsykova,A.V., Barczak,A.K., Tsai,E.Y., Dascher,C.C., Brenner,M.B. and Goldfeld,A.E. (2003) Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol. Cell Biol., 23, 526-533.
19. Falvo,J.V., Brinkman,B.M., Tslytsykova,A.V., Tsai,E.Y., Yao,T.P., Kung,A.L. and Goldfeld,A.E. (2000) A stimulus-specific role for CREB-binding protein (CBP) in T cell receptor-activated tumor necrosis factor alpha gene expression. Proc. Natl Acad. Sci. USA, 97, 3925-3929.
20. Barthel,R. and Goldfeld,A.E. (2003) T cell-specific expression of the human TNF-alpha gene involves a functional and highly conserved chromatin signature in intron 3. J. Immunol., 171. 3612-3619.
21. Seiler-Tuyns,A., Dufour,N. and Spertini,F. (1999) Human tumor necrosis factor-alpha gene 3′ untranslated region confers inducible toxin responsiveness to homologous, promoter in monocytic THP-1 cells. J. Biol. Chem., 274, 21714-21718.
22. Shakhov,A.N., Collart,M.A., Vassalli,P., Nedospas̀ov,S.A. and Jongeneel,C.V. (1990) Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med., 171, 35-47.
23. Udalova,I.A., Knight,J.C., Vidal,V., Nedospasov,S.A. and Kwiatkowski,D. (1998) Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem., 273 21178-21186.
24. Kuprash,D.V., Udalova,I.A., Turetskaya,R.L., Rice,N.R. and Nedospasov,S.A. (1995) Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: Distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene, 11, 97-106.
25. Messer,G., Weiss,E.H. and Baeuerle,P.A. (1990) Tumor necrosis factor beta (TNF-beta) induces binding of the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter. Cytokine 2, 389-397.
26. Paul,N.L., Lenardo,M.J., Novak,K.D., Sarr,T., Tang,W.L. and Ruddle,N.H. (1990) Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: Role for NF-kappa B. J. Virol., 64, 5412-5419.
27. Fashena,S.J., Reeves,R. and Ruddle,N.H. (1992) A poly(dA-dT) upstream activating sequence binds high-mobility group 1 protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation. Mol. Cell Biol., 12, 894-903.
28. Kuprash,D.V., Boitchenko,V.E., Yarovinsky,F.O., Rice,N.R., Nordheim,A., Ruhlmann,A. and Nedospasov,S.A. (2002) Cyclosporin A blocks the expression of lymphotoxin alpha, but not lymphotoxin beta, in human peripheral blood mononuclear cells. Blood, 100, 1721-1727.
29. Worm,M.M., Tsytsykova,A. and Geha,R.S. (1998) CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. Eur. J. Immunol., 28, 901-906.
30. Kuprash,D.V., Osipovich,O.A., Pokholok,D.K., Alimzhanov,M.B., Biragyb,A., Turetskaya,R.L. and Nedospasov,S.A. (1996) Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation. J Immunol., 156, 2465-2472.
31. Voon,D.C., Subrata,L.S., Karimi,M., Ulgiati,D. and Abraham,L.J. (2004) TNF and phorbol esters induce lymphotoxin-beta expression through distinct pathways involving Ets and NF-kappa B family members.J. Immunol., 172, 4332-4341.
32. Ozaki,K., Ohnishi,Y., Iida,A., Sekine,A., Yamada,R., Tsunoda,T., Sato,H., Hori,M., Nakamura,Y. and Tanaka,T. (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet., 32, 650-654.
33. Ota,M., Katsuyama,Y., Kimura,A., Tsuchiya,K., Kondo,M., Naruse,T., Mizuki,N., Itoh,K., Sasazuki,T. and Inoko,H. (2001) A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics, 71, 263-270.
34. McGuire,W., Hill,A.V., Allsopp,C.E., Greenwood,B.M. and Kwiatkowski,D. (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature, 371, 508-510.
35. Alcais,A., Alter,A., Antoni,G., Orlova,M., Nguyen,V.T., Singh,M., Vanderborght,P.R., Katoch,K., Mira,M.T., Vu,H.T. et al. (2007) Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat. Genet., 39 517-522.
36. Sariban,E., Imamura,K., Luebbers,R. and Kufe,D. (1988) Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J. Clin. Invest., 81, 1506-1510.
37. Sung.S.J., Walters,J.A., Hudson,J. and Gimble,J.M. (1991) Tumor necrosis factor-alpha mRNA accumulation in human myelomonocytic cell lines. Role of transcriptional regulation by DNA sequence motifs and mRNA stabilization. J. Immunol., 147, 2047-2054.
38. Espel,E., Garcia-Sanz,J.A., Aubert,V., Menoud,V., Sperisen,P., Fernandez,N. and Spertini,F. (1996) Transcriptional and translational control of TNF-alpha gene expression in human monocytes by major histocompatibility complex class II ligands. Eur. J. Immunol., 26, 2417-2424.
39. Skoog,T., Hamsten,A. and Eriksson,P. (2006) Allele-specific chromatin remodeling of the tumor necrosis factor-alpha promoter. Biochem. Biophys. Res. Commun., 351, 777-783.
40. Ranjbar,S., Rajsbaum,R. and Goldfeld,A.E. (2006) Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus. J. Immunol., 176, 4182-4190.
41. Kuhnert,P., Peterhans,E. and Pauli,U. (1992) Chromatin structure and DNase I hypersensitivity in the transcriptionally active and inactive porcine tumor necrosis factor gene locus. Nucleic Acids Res., 20, 1943-1948.
42. Tsytsykova,A.V., Rajsbaum,R., Falvo,J.V., Ligeiro,F., Neely,S.R. and Goldfeld,A.E. (2007) Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers. Proc. Natl. Acad. Sci. USA, 104, 16850-16855.
43. Tumanov,A.V., Nedospasov,S.A. and Turetskaia,R.L. (1998) Chromatin organization in the tumor necrosis factor/lymphotoxin gene locus: correlation with tissue-specific expression. Mol. Biol. (Mosk), 32, 98-102.
44. Rozen,S. and Skaletsky,H.J. (2000) In Krawetz,S. and Misener,S. (eds), Bioinformatics Methods and Protocols: Methods in Molecular Biology. Humana Press, Totowa. NJ, pp. 365-386.
45. Rumakers,C., Ruijter,J.M., Deprez,R.H. and Moorman,A.F. (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett., 339, 62-66.
46. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
47. Takahashi,Y., Rayman,J.B. and Dynlacht,B.D. (2000) Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev., 14, 804-816.
48. De Gobbi,M., Viprakasit,V., Hughes,J.R., Fisher,C., Buckle,V.J., Ayyub,H., Gibbons,R.J., Vernimmen,D., Yoshinaga,Y., de Jong,P. et al. (2006) A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science, 312, 1215-1217.
49. Stewart,C.A., Horton,R., Allcock,R.J., Ashurst,J.L., Atrazhev,A.M., Coggill,P., Dunham,I., Forbes,S., Halls,K., Howson,J.M. et al. (2004) Complete MHC haplotype sequencing for common disease gene mapping. Genome Res., 14, 1176-1187.
50. Knight,J.C., Udalova,I., Hill,A.V, Greenwood,B.M., Peshu,N., Marsh,K. and Kwiatkowski,D. (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet., 22, 145-150.
51. Sandaltzopoulos,R. and Becker,P.B. (1994) Solid phase DNase I footprinting: Quick and versatile. Nucleic Acids Res., 22, 1511-1512.
52. Schreiber,E., Matthias,P., Muller,M.M. and Schaffner,W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res., 17, 6419.
53. Vyas,P., Vickers,M.A., Simmons,D.L., Ayyub,H., Craddock,C.F. and Higgs,D.R. (1992) Cis-acting sequences regulating expression of the human alpha-globin cluster lie within constitutively open chromatin. Cell, 69, 781-793.
54. Visel,A., Bristow,J. and Pennacchio,L.A. (2007) Enhancer identification through comparative genomics. Semin. Cell Dev. Biol., 18, 140-152.
55. Siepel,A., Bejerano,G., Pedersen,J.S., Hinrichs,A.S., Hou,M., Rosenbloom,K., Clawson,H., Spieth,J., Hillier,L.W., Richards,S. et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res., 15, 1034-1050.
56. Taylor,J., Tyekucheva,S., King,D.C., Hardison,R.C., Miller,W. and Chiaromonte,F. (2006) ESPERR: Learning strong and weak signals genomic sequence alignment to identify functional elements. Genome Res., 16, 1596-1604.
57. Kouzarides,T. (2007) Chromatin modifications and their function. Cell 128, 693-705.
58. Jongeneel,C.V. (1992) In Beutler,B. (ed.), Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press Ltd, New York, pp. 539-559.
59. Kuprash,D., Turetskaya,R., Boldin,M., Udalova,I., Kistanova,E., Smirnova,J. and Nedospasov,S. (1993) In Fiers,W. and Buurman,W.A. (eds), Tumour Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. Karger, Basel, pp. 19-26.
60. Corre,S. and Galibert,M.D. (2005) Upstream stimulating factors: Highly versatile stress-responsive transcription factors. Pigment Cell Res. 18, 337-348.
61. Read,M.L., Clark,A.R. and Docherty,K. (1993) The helix-loop-helix transcription factor USF (upstream stimulating factor) binds to a regulatory sequence of the human insulin gene enhancer. Biochem J, 295 (Pt 1), 233-237.
62. Chen,F.E. and Ghosh,G. (1999) Regulation of DNA binding by Rel/NF-kappaB transcription factors: Structural views. Oncogene, 18, 6845-6852.
63. Chen,F.E., Huang,D.B., Chen,Y.Q. and Ghosh,G. (1998) Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature, 391, 410-413.
64. Macian,F. (2005) NFAT proteins: Key regulators of T-cell development and function. Nat. Rev. Immunol., 5, 472-484.
65. Lee,D.U. and Rao,A. (2004) Molecular analysis of a locus control region in the T helper 2 cytokine gene cluster: A target for STAT6 but not GATA3. Proc. Natl. Acad. Sci. USA, 101, 16010-16015.
66. Monticelli,S., Lee,D.U., Nardone,J., Bolton,D.L. and Rao,A. (2005) Chromatin-based regulation of cytokine transcription in Th2 cells and mast cells. Int. Immunol., 17, 1513-1524.
67. Goldfeld,A.E., Doyle,C. and Maniatis,T. (1990) Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. USA, 87, 9769-9773.
68. Xie,T., Rowen,L., Aguado,B., Ahearn,M.E., Madan,A., Qin,S., Campbell,R.D. and Hood,L. (2003) Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res., 13, 2621-2636.
69. Kuprash,D.V., Udalova,I.A., Turetskaya,R.L., Kwiatkowski,D., Rice,N.R, and Nedospasov,S.A. (1999) Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J. Immunol., 162, 4045-4052.
70. Albertella,M.R. and Campbell,R.D. (1994) Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. Hum. Mol. Genet., 3, 793-799.
71. Semple,J.I., Brown,S.E., Sanderson,C.M. and Campbell,R.D. (2002) A distinct bipartite motif is required for the localization of inhibitory kappaB-like (IkappaBL) protein to nuclear speckles. Biochem. J., 361, 489-496.
72. Okamoto,K., Makino,S., Yoshikawa,Y., Takaki,A., Nagatsuka,Y., Ota,M., Tamiya,G., Kimura,A., Bahram,S. and Inoko,H. (2003) Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am. J. Hum. Genet., 72, 303-312.
73. Allcock,R.J., Christiansen,F.T. and Price,P. (1999) The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15. Immunogenetics, 49, 660-665.